B

BBLGW

Bone Biologics

16.90

0.000.00%
Closed09:30 05/02 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Assets

3.86M

3.74M

8.50M

6.68M

0

Total Current Assets

3.86M

3.74M

8.50M

6.68M

0

Total Non Current Assets

0

0

0

0

0

Total Liabilities

377.71K

831.40K

2.55M

99.91K

13.69M

Total Current Liabilities

377.71K

831.40K

2.55M

99.91K

13.69M

Total Non Current Liabilities

0

0

0

0

0

Total Equity

3.48M

2.91M

5.95M

6.58M

-13.69M

Total Stockholders Equity

3.48M

2.91M

5.95M

6.58M

-13.69M

Minority Interest

--

--

--

--

--

Total Liabilities & Shareholders Equity

3.86M

3.74M

8.50M

6.68M

0

Total Common Shares Outstanding

2.95M

534.24K

63.75K

43.12K

51.13K

Total Preferred Shares Outstanding

--

--

--

--

--